Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05925491
Title Pembrolizumab in Locally Advanced Sinonasal Carcinoma (NeoPeSino)
Acronym NeoPeSino
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituti Clinici Scientifici Maugeri SpA
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.